Tumor Test Marker YRA385 // YRA391

The Tumor Test Marker YRA385 // YRA391 is an advanced medical device for early cancer detection, utilizing a chemiluminescence immunoassay analyzer to detect 18 distinct tumor markers. This test kit plays a critical role in recognizing elevated tumor marker levels in the blood, which is essential for the diagnosis and identification of various malignant tumors. It offers a reliable and efficient solution for healthcare professionals seeking precision and accuracy in cancer diagnostics.

Market Price

The market price for tumor marker test kits can vary widely depending on the manufacturer, specific features, and quantity being purchased. Generally, these kits range from $500 to $1500 per box, depending on the specifications and certifications. For specific pricing on the Tumor Test Marker YRA385 // YRA391, we invite you to request a quote or utilize the Kalstein Plus platform for a quick and automated quotation.

Frequently Asked Questions

What is included in the Tumor Test Marker Kit? The kit includes all necessary reagents and instructions for performing the test, compatible with chemiluminescence immunoassay analyzers.

How many tests can be conducted with one kit? The kit is available in configurations of 50T/BOX, 100T/BOX, and 24T/BOX, allowing flexibility based on testing requirements.

Is the kit certified for use? Yes, the kit is certified with CE, ISO13485, and FSC, ensuring it meets international standards for medical diagnostics.

Advantages and Disadvantages

One of the primary advantages of the Tumor Test Marker is its ability to detect a wide range of markers, providing comprehensive diagnostic information. It is also compatible with CLIA technology, increasing its accuracy and reliability. However, potential disadvantages may include the need for specific storage conditions (2-8°C) and calibration (2/6 points) requirements, which may necessitate additional resources and attention from users.

Product Use in the Field

In practical scenarios, the Tumor Test Marker YRA385 // YRA391 is used extensively in hospitals, diagnostic labs, and research institutions. It facilitates early cancer detection through routine blood sample analysis, providing clinicians with crucial data to identify potential malignancies promptly.

Recommendations

To maximize the effectiveness of the Tumor Test Marker, it is recommended to ensure proper storage and handling of the test kits. Regular calibration of the chemiluminescence immunoassay analyzers is also advised to maintain accuracy. Additionally, training healthcare professionals on the use of the test kits can further enhance diagnostic precision and patient outcomes.

Features

• Detection of 18 different tumor markers
• Compatible with chemiluminescence immunoassay analyzers
• Certified with CE, ISO13485, and FSC
• Available in 50T/BOX, 100T/BOX, and 24T/BOX

Technical Specifications